Trademarkia Logo

Canada

C$
Trademark Search in Canada
LysoScore

View On IC.GC.CA

LysoScore
APPROVED

on 18 Mar 2025

Last Applicant/ Owned by

Samsara Therapeutics

Afrikahaus, Große Reichenstraße 2720457 Hamburg

DE

Serial Number

2244284 filed on 19th Jan 2023

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

LysoScore

Trademark usage description

scientific and technological research in the fields of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, t Read More

Classification Information

Class [042]
Scientific and technological research in the fields of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, therapeutics, chemistry and biochemistry; scientific industrial design services; technological industrial design services; pharmaceutical research and development; research and development of new products for others; pharmaceutical drug development services; scientific laboratory research services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; database services, namely, cloud computing provider services for general storage of data; design, engineering, research, development and testing services in the fields of pharmaceuticals, biotechnology, biology, biomedicine, genetics, molecular sciences, therapeutics, chemistry and biochemistry for medical, scientific, and technological applications; preparation of scientific analyzes and evaluations namely, testing of pharmaceuticals and pharmaceutical product evaluation; consulting services in the field of pharmaceutical research and development; consulting services in the field of medical testing services; pharmaceutical products development; development of pharmaceutical preparations and medicines; medical laboratory services.

Classification kind code

12

Class [044]
Consulting services in the field of pharmaceutical research and development; medical diagnostic testing services; consultancy in the medical aspect of pharmaceuticals; pharmaceutical consultancy; medical analysis services relating to the diagnosis and treatment of persons; laboratory analysis services relating to the diagnosis and treatment of persons in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases; medical examinations; medical analysis services relating to the treatment of patients for diagnosing and treating neurodegenerative diseases, monogenic diseases, cancer, neurological diseases, immunological diseases, cardiovascular diseases, and metabolic diseases; medical screening; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical testing for diagnostic and treatment purposes in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases.

Classification kind code

12

Mark Details

Serial Number

2244284

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 4th Mar 2025		Agent Changed
Submitted for opposition 22
on 31st May 2024		Search Recorded
Submitted for opposition 20
on 31st May 2024		Examiner's First Report
Submitted for opposition 223
on 31st May 2024		Total Provisional Refusal
Submitted for opposition 256
on 9th Jan 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 9th Mar 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 8th Mar 2023		Created
Submitted for opposition 31
on 8th Mar 2023		Formalized
Submitted for opposition 228
on 19th Jan 2023		International Registration
Submitted for opposition 30
on 19th Jan 2023		Filed